Contract 75N94021P00813
Applied Stemcell, Inc. · Department Of Health And Human Services · September 2, 2021
Applied Stemcell, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 2, 2021 for $14,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Bethesda, MD. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N94021P00813
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Drugs And Biologicals
- Place of performance
- Bethesda, MD
- First action
- September 2, 2021
Description
POINT MUTATION IPS/ES CELL LINE GENERATION USING CRISPR/CAS9
Modification timeline
-
September 2, 2021Base award$13.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N94021P00813?
Contract 75N94021P00813 is a federal contract awarded to Applied Stemcell, Inc. by Department Of Health And Human Services on September 2, 2021 for $14,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75N94021P00813?
Applied Stemcell, Inc. won contract 75N94021P00813 from Department Of Health And Human Services.
How much is contract 75N94021P00813 worth?
Contract 75N94021P00813 has obligated $14,000 to date.